ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Bonner to Succeed Stovall as NCCS President and CEO.

May 30, 2008

Preventive Oncology Announcement Withdrawn For Modification

April 3, 1981

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union

June 19, 1998

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010